1-8 of 8
Fiona He, MD
Close
Sort by
Journal Articles

JAK/STAT Inhibition Targets TP53 altered Primary Human Acute Myeloid Leukemia Stem Cells

Marie Lue Antony, PhD, Klara Noble-Orcutt, BS, MS, Yoonku Lee, MS, Oluwateniayo Ogunsan, Jeffrey Lee Jensen, MD PhD, Fiona He, MD, Zohar Sachs, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-142993
Published: 2020
Journal Articles

Age-Based Probability of Ten-Year Overall Survival (OS) of Acute Myeloid Leukemia (AML): A National Cancer Database (NCDB) Analysis

Vijaya R. Bhatt, MD, Valerie K Shostrom, Nabin Khanal, MBBS, Chakra P Chaulagain, MD, Fiona He, MD, Krishna Gundabolu, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-134434
Published: 2020
Journal Articles

High Incidence of Venous Thromboembolism in Patients with Chronic Graft-Versus-Host Disease

Najla El Jurdi, MD, Heba Elhusseini, MD, Todd E. DeFor, MS, Grigori Okoev, MD PhD, Aleksandr Lazaryan, MDPhDMPH, John Rogosheske, PharmD, Kristen Weiler, Veronika Bachanova, MD PhD, Brian C. Betts, MD, Bruce R. Blazar, MD, Claudio G. Brunstein, MD PhD, Fiona He, MD, Shernan G Holtan, MD, Murali Janakiram, MD, Radhika Gangaraju, MD, Joseph E. Maakaron, MD, Margaret L. MacMillan, MD, Armin Rashidi, MD PhD, Erica D. Warlick, MD, Smita Bhatia, MDMPH, Joan D. Beckman, MDPhD, Gregory M Vercellotti, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–46.
https://doi.org/10.1182/blood-2020-136337
Published: 2020
Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer (NK) Cells in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma

Veronika Bachanova, MD PhD, Joseph Maakaron, MD, David H. McKenna, MD, Qing Cao, MS, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Ronit Simantov, MD, Tracey Lodie, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
https://doi.org/10.1182/blood-2020-142419
Published: 2020
Journal Articles

High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+3

Bhaskar Kolla, MBBS, Nurul Aidah Abdul Halim, MBBS, Zohar Sachs, MD PhD, Erica D. Warlick, MD, Daniel J. Weisdorf, MD, Fiona He, MD, Lao Zhentang, MBBS, MRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 3432.
https://doi.org/10.1182/blood-2019-123306
Published: 2019
Journal Articles

Cell Type-Specific Effects of Crizotinib in Human Acute Myeloid Leukemia with TP53 Alterations

Marie Lue Antony, PhD, Klara Noble-Orcutt, Oluwateniayo Ogunsan, Fiona He, MD, Zohar Sachs, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2563.
https://doi.org/10.1182/blood-2019-130487
Published: 2019
Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

Veronika Bachanova, MD PhD, David H. McKenna, MD, Xianghua Luo, PhD, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD MS, Erica D. Warlick, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Guy Brachya, PhD, Tony Peled, MSc, Jeffrey S. Miller, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 777.
https://doi.org/10.1182/blood-2019-130476
Published: 2019
Journal Articles

Neurological Consequences of Cytokine Release Syndrome Following Subcutaneous Recombinant IL-15 and Haploidentical Donor Natural Killer Cell Therapy for Advanced Acute Myeloid Leukemia

Sarah Cooley, MD, Fiona He, MD BS, BA, Veronika Bachanova, MD PhD, Greg M Vercellotti, MD FACP, Todd E. DeFor, MS, Julie Curtsinger, Paul Alexander Robertson, MD, Kevin C Conlon, MD, Thomas A Waldmann, MD, David H. McKenna, MD, Bruce Blazar, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2649.
https://doi.org/10.1182/blood.V130.Suppl_1.2649.2649
Published: 2017